See Policy CPT/HCPCS CODE section below for any prior authorization requirements
|
|
- Amos Stafford
- 5 years ago
- Views:
Transcription
1 Effective Date: 1/1/2019 Section: SUR Policy No: 395 1/1/19 Medical Policy Committee Approved Date: 8/17; 2/18; 12/18 Medical Officer Date APPLIES TO: Medicare Only See Policy CPT/HCPCS CODE section below for any prior authorization requirements BENEFIT APPLICATION CRITERIA This policy is based on the Centers for Medicare & Medicaid Services (CMS) National Coverage Determination (NCD) for for Essential Tremor and Parkinson s Disease (160.24), National Coverage Determination (NCD) for Electrical Nerve Stimulators (160.7), and National Coverage Determination (NCD) for Treatment of Motor Function Disorders with Electric Nerve Stimulation (160.2). 1-3 NCD for for Essential Tremor and Parkinson s Disease (160.24) I. Effective for services furnished on or after April 1, 2003, Medicare will cover unilateral or bilateral thalamic ventralis intermedius nucleus (VIM) deep brain stimulation (DBS) for the treatment of essential tremor (ET) and/or Parkinsonian tremor and unilateral or bilateral subthalamic nucleus (STN) or globus pallidus interna (GPi) DBS for the treatment of Parkinson's disease (PD) only under the following (A.-C.) conditions: A. Medicare will only consider DBS devices to be reasonable and necessary if they are Food and Drug Administration (FDA) approved devices for DBS or devices used in accordance with FDA approved protocols governing Category B Investigational Device Exemption (IDE) DBS clinical trials. B. For thalamic VIM DBS to be considered reasonable and necessary, patients must meet all of the following criteria: 1. Diagnosis of ET based on postural or kinetic tremors of hand(s) without other neurologic signs, or diagnosis of idiopathic PD (presence of at least 2 cardinal PD features (tremor, rigidity or bradykinesia)) which is of a tremor-dominant form. 2. Marked disabling tremor of at least level 3 or 4 on the Fahn-Tolosa-Marin Clinical Tremor Rating Scale (or equivalent scale) in the extremity intended for treatment, causing significant limitation in daily activities despite optimal medical therapy. Page 1 of 7
2 3. Willingness and ability to cooperate during conscious operative procedure, as well as during post-surgical evaluations, adjustments of medications and stimulator settings. C. For STN or GPi DBS to be considered reasonable and necessary, patients must meet all of the following criteria: 1. Diagnosis of PD based on the presence of at least 2 cardinal PD features (tremor, rigidity or bradykinesia). 2. Advanced idiopathic PD as determined by the use of Hoehn and Yahr stage or Unified Parkinson's Disease Rating Scale (UPDRS) part III motor subscale. 3. L-dopa responsive with clearly defined "on" periods. 4. Persistent disabling Parkinson's symptoms or drug side effects (e.g., dyskinesias, motor fluctuations, or disabling "off" periods) despite optimal medical therapy. 5. Willingness and ability to cooperate during conscious operative procedure, as well as during post-surgical evaluations, adjustments of medications and stimulator settings. II. The DBS is not reasonable and necessary and is not covered for ET or PD patients with any of the following (A.-H.): A. Non-idiopathic Parkinson's disease or "Parkinson's Plus" syndromes. B. Cognitive impairment, dementia or depression, which would be worsened by or would interfere with the patient's ability to benefit from DBS. C. Current psychosis, alcohol abuse or other drug abuse. D. Structural lesions such as basal ganglionic stroke, tumor or vascular malformation as etiology of the movement disorder. E. Previous movement disorder surgery within the affected basal ganglion. F. Significant medical, surgical, neurologic or orthopedic co-morbidities contraindicating DBS surgery or stimulation. G. Patients who undergo DBS implantation should not be exposed to diathermy (deep heat treatment including shortwave diathermy, microwave diathermy and ultrasound diathermy) or any type of MRI, which may adversely affect the DBS system or adversely affect the brain around the implanted electrodes. H. The DBS should be performed with extreme caution in patients with cardiac pacemakers or other electronically controlled implants, which may adversely affect or be affected by the DBS system. III. For DBS lead implantation to be considered reasonable and necessary, providers and facilities must meet all of the following (A.-D.) criteria: A. Neurosurgeons must: 1. Be properly trained in the procedure; 2. Have experience with the surgical management of movement disorders, including DBS therapy; and 3. Have experience performing stereotactic neurosurgical procedures. B. Operative teams must have training and experience with DBS systems, including knowledge of anatomical and neurophysiological characteristics for localizing the targeted nucleus, surgical and/or implantation techniques for the DBS system, and operational and functional Page 2 of 7
3 characteristics of the device. C. Physicians specializing in movement disorders must be involved in both patient selection and post-procedure care. D. Hospital medical centers must have: 1. Brain imaging equipment (MRI and/or CT) for pre-operative stereotactic localization and targeting of the surgical site(s); 2. Operating rooms with all necessary equipment for stereotactic surgery; and 3. Support services necessary for care of patients undergoing this procedure and any potential complications arising intraoperatively or postoperatively. NCD for Electrical Nerve Stimulators (160.7) IV. The implantation of central nervous system stimulators may be covered as therapies for the relief of chronic intractable pain, subject to the following (A.-B.) conditions: A. There are two types of implantations covered by this instruction: 1. Dorsal Column (Spinal Cord) Neurostimulation - The surgical implantation of neurostimulator electrodes within the dura mater (endodural) or the percutaneous insertion of electrodes in the epidural space is covered. 2. Depth Brain Neurostimulation - The stereotactic implantation of electrodes in the deep brain (e.g., thalamus and periaqueductal gray matter) is covered. B. No payment may be made for the implantation of dorsal column or depth brain stimulators or services and supplies related to such implantation, unless all of the conditions listed below have been met: 1. The implantation of the stimulator is used only as a late resort (if not a last resort) for patients with chronic intractable pain; 2. With respect to item a, other treatment modalities (pharmacological, surgical, physical, or psychological therapies) have been tried and did not prove satisfactory, or are judged to be unsuitable or contraindicated for the given patient; 3. Patients have undergone careful screening, evaluation and diagnosis by a multidisciplinary team prior to implantation. (Such screening must include psychological, as well as physical evaluation); 4. All the facilities, equipment, and professional and support personnel required for the proper diagnosis, treatment training, and follow up of the patient (including that required to satisfy item c) must be available; and 5. Demonstration of pain relief with a temporarily implanted electrode precedes permanent implantation. NCD for Treatment of Motor Function Disorders with Electric Nerve Stimulation (160.2) V. While electric nerve stimulation has been employed to control chronic intractable pain for some time, its use in the treatment of motor function disorders, such as multiple sclerosis, is a recent innovation, and the medical effectiveness of such therapy has not been verified by scientifically controlled studies. VI. Where electric nerve stimulation is employed to treat motor function disorders, no reimbursement Page 3 of 7
4 may be made for the stimulator or for the services related to its implantation since this treatment cannot be considered reasonable and necessary. CPT/HCPCS CODES Medicare Only Prior Authorization Required Twist drill or burr hole(s) for implantation of neurostimulator electrodes, cortical Craniectomy or craniotomy for implantation of neurostimulator electrodes, cerebral, cortical Twist drill, burr hole, craniotomy, or craniectomy with stereotactic implantation of subthalamic nucleus, periventricular, periaqueductal gray), without use of intraoperative microelectrode recording; first array Twist drill, burr hole, craniotomy, or craniectomy with stereotactic implantation of subthalamic nucleus, periventricular, periaqueductal gray), without use of intraoperative microelectrode recording; each additional array (List separately in addition to primary procedure) Twist drill, burr hole, craniotomy, or craniectomy with stereotactic implantation of subthalamic nucleus, periventricular, periaqueductal gray), with use of intraoperative microelectrode recording; first array Twist drill, burr hole, craniotomy, or craniectomy with stereotactic implantation of subthalamic nucleus, periventricular, periaqueductal gray), with use of intraoperative microelectrode recording; each additional array (List separately in addition to primary procedure) Revision or removal of intracranial neurostimulator electrodes Insertion or replacement of cranial neurostimulator pulse generator or receiver, direct or inductive coupling; with connection to a single electrode array Insertion or replacement of cranial neurostimulator pulse generator or receiver, direct or inductive coupling; with connection to 2 or more electrode arrays Revision or removal of cranial neurostimulator pulse generator or receiver Electrocorticogram from an implanted brain neurostimulator pulse generator/transmitter, including recording, with interpretation and written report, up to 30 days Electronic analysis of implanted neurostimulator pulse generator/transmitter (eg, contact Page 4 of 7
5 other qualified health care professional; with simple cranial nerve neurostimulator pulse generator/transmitter programming by physician or other qualified health care professional Electronic analysis of implanted neurostimulator pulse generator/transmitter (eg, contact other qualified health care professional; with complex cranial nerve neurostimulator pulse generator/transmitter programming by physician or other qualified health care professional Electronic analysis of implanted neurostimulator pulse generator system (eg, rate, pulse amplitude and duration, battery status, electrode selectability and polarity, impedance and patient compliance measurements), complex deep brain neurostimulator pulse generator/transmitter, with initial or subsequent programming; first hour Electronic analysis of implanted neurostimulator pulse generator system (eg, rate, pulse amplitude and duration, battery status, electrode selectability and polarity, impedance and patient compliance measurements), complex deep brain neurostimulator pulse generator/transmitter, with initial or subsequent programming; each additional 30 minutes after first hour (List separately in addition to code for primary procedure) Electronic analysis of implanted neurostimulator pulse generator/transmitter (eg, contact other qualified health care professional; with brain neurostimulator pulse generator/transmitter programming, first 15 minutes face-to-face time with physician or other qualified health care professional Electronic analysis of implanted neurostimulator pulse generator/transmitter (eg, contact other qualified health care professional; with brain neurostimulator pulse generator/transmitter programming, each additional 15 minutes face-to-face time with physician or other qualified health care professional (List separately in addition to code for primary procedure) C1767 Generator, neurostimulator (implantable), non-rechargeable C1778 Lead, neurostimulator (implantable) C1816 Receiver and/or transmitter, neurostimulator (implantable) C1820 Generator, neurostimulator (implantable), with rechargeable battery and charging system C1823 Generator, neurostimulator (implantable), non-rechargeable, with transvenous sensing and stimulation leads C1883 Adapter/, pacing lead or neurostimulator lead (implantable) C1897 Lead, neurostimulator test kit (implantable) L8679 Implantable neurostimulator, pulse generator, any type L8680 Implantable neurostimulator electrode, each Page 5 of 7
6 L8681 L8682 L8683 L8685 L8686 L8687 L8688 Patient programmer (external) for use with implantable programmable neurostimulator pulse generator, replacement only Implantable neurostimulator radiofrequency receiver Radiofrequency transmitter (external) for use with implantable neurostimulator radiofrequency receiver Implantable neurostimulator pulse generator, single array, rechargeable, includes Implantable neurostimulator pulse generator, single array, non-rechargeable, includes Implantable neurostimulator pulse generator, dual array, rechargeable, includes Implantable neurostimulator pulse generator, dual array, non-rechargeable, includes No Prior Authorization Required Electronic analysis of implanted neurostimulator pulse generator system (eg, rate, pulse amplitude, pulse duration, configuration of wave form, battery status, electrode selectability, output modulation, cycling, impedance and patient compliance measurements); simple or complex brain, spinal cord, or peripheral (ie, cranial nerve, peripheral nerve, sacral nerve, neuromuscular) neurostimulator pulse generator/transmitter, without reprogramming L8689 External recharging system for battery (internal) for use with implantable neurostimulator, replacement only Unlisted Codes All unlisted codes will be reviewed for medical necessity, correct coding, and pricing at the claim level. If an unlisted code is billed related to services addressed in this policy then priorauthorization is required Unlisted procedure, nervous system INSTRUCTIONS FOR USE Providence Health Assurance (PHA) Medical Policies serve as guidance for the administration of plan benefits. Medical policies do not constitute medical advice nor a guarantee of coverage. PHA Medical Policies are reviewed annually and are based upon Centers for Medicare & Medicaid (CMS) coverage guidance available as of the last policy update. PHA reserves the right to determine the application of Medical Policies and make revisions to its Medical Policies at any time. Providers will be given at least 60-days notice of policy changes that are restrictive in nature. The scope and availability of all plan benefits are determined in accordance with the applicable coverage agreement. Any conflict or variance between the terms of the coverage agreement and PHA Medical Policy will be resolved in favor of the coverage agreement. Page 6 of 7
7 REGULATORY STATUS Mental Health Parity Statement Coverage decisions are made on the basis of individualized determinations of medical necessity and the experimental or investigational character of the treatment in the individual case. REFERENCES 1. Centers for Medicare & Medicaid Services (CMS) National Coverage Determination (NCD) for for Essential Tremor and Parkinson s Disease (160.24). 2003; ion=nca%7ccal%7cncd%7cmedcac%7cta%7cmcd&articletype=sad%7ced&policytype=bot h&s=44&keyword=deep+brain+stimulation&keywordlookup=doc&keywordsearchtype=exact &kq=true&bc=iaaaacaaaaaaaa%3d%3d&. Accessed 7/6/ Centers for Medicare & Medicaid Services National Coverage Determination: Electrical Nerve Stimulators (160.7). 1995; Accessed 7/6/ Centers for Medicare & Medicaid Services National Coverage Determination (NCD): Treatment of Motor Function Disorders with Electric Nerve Stimulation (160.2). 2003; Accessed 7/6/2017. Page 7 of 7
MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: MP.108.MH Last Review Date: 05/10/2018 Effective Date: 07/01/2018
MedStar Health, Inc. POLICY AND PROCEDURE MANUAL MP.0108.MH Deep Brain and Dorsal Column (Spinal Cord) This policy applies to the following lines of business: MedStar Employee (Select) MedStar CareFirst
More information2016 HF10 THERAPY REIMBURSEMENT REFERENCE GUIDE
206 HF0 THERAPY REIMBURSEMENT REFERENCE GUIDE HF0 therapy, delivered by the Nevro Senza System, is a new high-frequency spinal cord stimulation technology designed to aid in the management of chronic intractable
More informationH F 1 0 T H E R A P Y R E I M B U R S E M E N T R E F E R E N C E G U I D E
HF10 therapy, delivered by the Nevro Senza System, is the high-frequency spinal cord stimulation technology designed to aid in the management of chronic intractable pain of the trunk/limbs without paresthesia.
More information2 016 HF10 THERAPY HOSPITAL OUTPATIENT DEPARTMENT AND AMBULATORY SURGERY CENTER REIMBURSEMENT REFERENCE GUIDE
HF10 therapy, delivered by the Nevro Senza System, is a new high-frequency spinal cord stimulation technology designed to aid in the management of chronic intractable pain of the trunk/limbs, including
More informationDeep Brain Stimulation (DBS)
Deep Brain Stimulation (DBS) [For the list of services and procedures that need preauthorization, please refer to www.mcs.com.pr go to Comunicados a Proveedores, and click Cartas Circulares.] Medical Policy:
More informationMP.0108.MH Deep Brain and Dorsal Column (Spinal Cord) Neurostimulators
MedStar Health, Inc. POLICY AND PROCEDURE MANUAL MP.0108.MH Deep Brain and Dorsal Column (Spinal Cord) This policy applies to the following lines of business: MedStar Employee (Select) MedStar MA DSNP
More informationNevro Reimbursement Support
HF10 therapy, delivered by the Nevro Senza System, is the high-frequency spinal cord stimulation technology operated at 10,000 Hz designed to aid in the management of chronic intractable pain of the trunk
More informationHF10 THERAPY 2018 Ambulatory Surgery Center Reimbursement and Coding Reference Guide
HF10 therapy, delivered by the Nevro Senza System, is the high-frequency spinal cord stimulation technology operated at 10,000 Hz designed to aid in the management of chronic intractable pain of the trunk
More informationMedical Review Criteria Implantable Neurostimulators
Medical Review Criteria Implantable Neurostimulators Subject: Implantable Neurostimulators Effective Date: April 14, 2017 Authorization: Prior authorization is required for covered implantable stimulators
More informationClinical Policy Title: Deep brain stimulation
Clinical Policy Title: Deep brain stimulation Clinical Policy Number: 09.03.02 Effective Date: July 1, 2015 Initial Review Date: February 18, 2015 Most Recent Review Date: March 16, 2016 Next Review Date:
More informationPACEMAKERS ARE NOT JUST FOR THE HEART! Ab Siadati MD
PACEMAKERS ARE NOT JUST FOR THE HEART! Ab Siadati MD WHAT IS DEEP BRAIN STIMULATION? WHY SHOULD YOU CONSIDER DBS SURGERY FOR YOUR PATIENTS? HOW DOES DBS WORK? DBS electrical stimulation overrides abnormal
More informationPunit Agrawal, DO Clinical Assistant Professor of Neurology Division of Movement Disorders OSU Department of Neurology
Deep Brain Stimulation for Movement Disorders Punit Agrawal, DO Clinical Assistant Professor of Neurology Division of Movement Disorders OSU Department of Neurology History of DBS 1 History of DBS 1987
More informationHighmark Medical Policy Bulletin
Highmark Medical Policy Bulletin Section: Miscellaneous Number: Z 7 Topic: Electrical Nerve Stimulation Effective Date: March 3, 2003 Issued Date: November 1, 2003 Date Last Reviewed: 12/2002 General Policy
More informationDeep Brain Stimulation for Parkinson s Disease & Essential Tremor
Deep Brain Stimulation for Parkinson s Disease & Essential Tremor Albert Fenoy, MD Assistant Professor University of Texas at Houston, Health Science Center Current US Approvals Essential Tremor and Parkinsonian
More informationDeep Brain Stimulation: Patient selection
Deep Brain Stimulation: Patient selection Halim Fadil, MD Movement Disorders Neurologist Kane Hall Barry Neurology Bedford/Keller, TX 1991: Thalamic (Vim) DBS for tremor Benabid AL, et al. Lancet. 1991;337(8738):403-406.
More informationSurgical Treatment: Patient Edition
Parkinson s Disease Clinic and Research Center University of California, San Francisco 505 Parnassus Ave., Rm. 795-M, Box 0114 San Francisco, CA 94143-0114 (415) 476-9276 http://pdcenter.neurology.ucsf.edu
More informationDEEP BRAIN STIMULATION
DEEP BRAIN STIMULATION Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
More informationSurgical Treatment of Movement Disorders. Surgical Treatment of Movement Disorders. New Techniques: Procedure is safer and better
Surgical Treatment of Movement Stephen Grill, MD, PHD Johns Hopkins University and Parkinson s and Movement Center of Maryland Surgical Treatment of Movement Historical Aspects Preoperative Issues Surgical
More informationSurgical Treatment for Movement Disorders
Surgical Treatment for Movement Disorders Seth F Oliveria, MD PhD The Oregon Clinic Neurosurgery Director of Functional Neurosurgery: Providence Brain and Spine Institute Portland, OR Providence St Vincent
More informationUnderstand the New 2019 Neurostimulator Analysis-Programming CPT Coding Structure and Associated Relative Value Units
Understand the New 2019 Neurostimulator Analysis-Programming CPT Coding Structure and Associated Relative Units The American Academy of Neurology (AAN) presents the following case studies to help you understand
More informationDBS THERAPY FOR ESSENTIAL TREMOR, PARKINSON S DISEASE, DYSTONIA AND OBSESSIVE- COMPULSIVE DISORDER COMMONLY BILLED CODES EFFECTIVE JANUARY 2017
FOR ESSENTIAL TREMOR, PARKINSON S DISEASE, DYSTONIA AND OBSESSIVE- COMPULSIVE DISORDER EFFECTIVE JANUARY 2017 Medtronic provides this information for your convenience only. It does not constitute legal
More informationClinical Policy Title: Deep brain stimulation
Clinical Policy Title: Deep brain stimulation Clinical Policy Number: 09.03.02 Effective Date: July 1, 2015 Initial Review Date: February 18, 2015 Most Recent Review Date: March 15, 2017 Next Review Date:
More informationEffective Date: 1/1/2019 Section: MED Policy No: 391 Medical Policy Committee Approved Date: 6/17; 12/18
Effective Date: 1/1/2019 Section: MED Policy No: 391 Medical Policy Committee Approved Date: 6/17; 12/18 1/1/2019 Medical Officer Date APPLIES TO: Medicare Only See Policy CPT/HCPCS CODE section below
More informationCortical Stimulation for Epilepsy (NeuroPace )
(NeuroPace ) Last Review Date: October 13, 2017 Number: MG.MM.SU.69 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit
More informationDeep Brain Stimulation
Deep Brain Stimulation Policy Number: 7.01.63 Last Review: 8/2017 Origination: 8/2001 Next Review: 8/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for deep brain
More informationDeep Brain Stimulation and Movement Disorders
Deep Brain Stimulation and Movement Disorders Farrokh Farrokhi, MD Neurosurgery Maria Marsans, PA-C Neurosurgery Virginia Mason June 27, 2017 OBJECTIVES Understand the role of Deep Brain Stimulation (DBS)
More informationNeuromuscular Electrical Stimulator (NMES) Corporate Medical Policy
Neuromuscular Electrical Stimulator (NMES) Corporate Medical Policy File name: Neuromuscular Electrical Stimulator (NMES) File Code: UM.NS.04 Origination: 05/01/2007 Last Review: 06/2018 Next Review: 06/2019
More informationClinical Policy Title: Deep brain stimulation
Clinical Policy Title: Deep brain stimulation Clinical Policy Number: 09.03.02 Effective Date: July 1, 2015 Initial Review Date: February 18, 2015 Most Recent Review Date: February 6, 2018 Next Review
More informationAll Indiana Health Coverage Programs Hospitals, Ambulatory Surgical Centers, Physicians, and Durable Medical Equipment Providers
P R O V I D E R B U L L E T I N B T 2 0 0 0 3 2 S E P T E M B E R 8, 2 0 0 0 To: Subject: All Indiana Health Coverage Programs Hospitals, Ambulatory Surgical Centers, Physicians, and Durable Medical Equipment
More informationEMERGING TREATMENTS FOR PARKINSON S DISEASE
EMERGING TREATMENTS FOR PARKINSON S DISEASE Katerina Markopoulou, MD, PhD Director Neurodegenerative Diseases Program Department of Neurology NorthShore University HealthSystem Clinical Assistant Professor
More informationDeep Brain Stimulation: Indications and Ethical Applications
Deep Brain Stimulation Overview Kara D. Beasley, DO, MBe, FACOS Boulder Neurosurgical and Spine Associates (303) 562-1372 Deep Brain Stimulation: Indications and Ethical Applications Instrument of Change
More information1. POLICY: Magnetic Resonance Image Guided High Intensity Focused Ultrasound (MRgFUS) for Essential Tremor
Retired Date: Page 1 of 10 1. POLICY: Magnetic Resonance Image (MRgFUS) for Essential Tremor 2. RESPONSIBLE PARTIES: Medical Management Administration, Utilization Management, Integrated Care Management,
More informationDBS Programming. Paul S Fishman MD, PhD University of Maryland School of Medicine PFNCA 3/24/18
DBS Programming Paul S Fishman MD, PhD University of Maryland School of Medicine PFNCA 3/24/18 Disclosure The University of Maryland has received research funding form InSightec and the Focused Ultrasound
More informationInspire Medical Systems. Hospital Billing Guide
Inspire Medical Systems Hospital Billing Guide Inspire Medical Systems Hospital Billing Guide This Hospital Billing Guide was developed to help centers correctly bill for Inspire Upper Airway Stimulation
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: spinal_cord_stimulation 3/1980 10/2017 10/2018 10/2017 Description of Procedure or Service Spinal cord stimulation
More information10/13/2017. Disclosures. Deep Brain Stimulation in the Treatment of Movement Disorders. Deep Brain Stimulation: Objectives.
Deep Brain Stimulation in the Treatment of Movement Disorders Disclosures None Eleanor K Orehek, M.D. Movement Disorders Specialist Noran Neurological Clinic 1 2 Objectives To provide an overview of deep
More informationABBOTT CODING GUIDE CHRONIC PAIN. Effective January 1, 2019 INTRO SPINAL CORD STIMULATION (SCS) RADIOFREQUENCY ABLATION (RFA)
ABBOTT CODING GUIDE CHRONIC PAIN Effective January 1, 2019 CHRONIC PAIN Effective January 1, 2019 Introduction The Chronic Pain Coding Guide is intended to provide reference material related to general
More informationDEEP BRAIN AND CORTICAL STIMULATION
UnitedHealthcare Community Plan Medical Policy DEEP BRAIN AND CORTICAL STIMULATION Policy Number: CS030.F Effective Date: August 1, 2017 Table of Contents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS...
More informationAT THE FOREFRONT OF MENDING THE BRAIN
AT THE FOREFRONT OF MENDING THE BRAIN Abbott's neuromodulation portfolio fuels earnings growth while offering lifechanging treatment Many people who are dealt with a diagnosis of Parkinson's disease or
More informationInspire Medical Systems. Physician Billing Guide
Inspire Medical Systems Physician Billing Guide 2019 Inspire Medical Systems Physician Billing Guide This Physician Billing Guide was developed to help providers correctly bill for Inspire Upper Airway
More informationOriginal Policy Date
MP 7.01.48 Deep Brain Stimulation Medical Policy Section Surgery Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013 Return to Medical Policy Index
More informationParkinson s disease, Essential Tremor and primary dystonia
Parkinson s disease, Essential Tremor and primary dystonia What is Deep Brain Stimulation and how does it work? Deep Brain Stimulation (DBS) uses one or two surgically implanted medical devices, similar
More informationNeurostimulators and Neuromuscular
Neurostimulators and Neuromuscular Stimulators Chapter.1 Enrollment..................................................................... -2.2 Benefits, Limitations, and Authorization Requirements...........................
More informationPOLICIES AND PROCEDURE MANUAL
POLICIES AND PROCEDURE MANUAL Policy: MP021 Section: Medical Benefit Policy Subject: Dorsal Column Stimulation I. Policy: Dorsal Column StimulationRx therapy II. Purpose/Objective: To provide a policy
More informationMedical Policy Deep Brain Stimulation. Description. Related Policies. Policy. Subsection. Effective Date February 27,
7.01.63 Deep Brain Stimulation Section 7.0 Surgery Subsection Effective Date February 27, 2015 Original Policy Date December 18, 2009 Next Review Date February 2016 Medical Policy Description Deep brain
More informationPARKINSON S SYMPTOM TRACKER
PARKINSON S SYMPTOM You can help your doctor make good treatment decisions by tracking your symptoms. A well-kept Symptom Tracker provides a clear picture of when you are taking your medications, when
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Implanted Peripheral Nerve Stimulator (PNS) for Pain Control Page 1 of 6 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Implanted Peripheral Nerve Stimulator (PNS)
More informationNeurostimulator Devices and Supplies
Neurostimulator Devices and Supplies Chapter.1 Enrollment..................................................................... -2.2 Benefits, Limitations, and Authorization Requirements...........................
More informationDEEP BRAIN AND CORTICAL STIMULATION
UnitedHealthcare Commercial Medical Policy DEEP BRAIN AND CORTICAL STIMULATION Policy Number: 2018T0321T Effective Date: February 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS...
More informationIntrathecal Opioid Therapy for Management of Chronic Pain
Intrathecal Opioid Therapy for Management of Chronic Pain Date of Origin: 01/2000 Last Review Date: 09/27/2017 Effective Date: 09/27/2017 Dates Reviewed: 11/2002, 12/2003, 12/2004, 12/2005, 12/2006, 12/2007,
More informationSurgical Options. A History of Surgical Treatment. Patient selection. Essential Tremor (ET)
Essential tremor (ET) is the most common movement disorder, impacting the lives of an estimated 10 million Americans and millions more worldwide. At this time, there is no cure for ET and only about 50%
More informationNational Imaging Associates, Inc. Clinical guidelines FACET JOINT INJECTIONS, MEDIAL BRANCH BLOCKS, AND FACET JOINT RADIOFREQUENCY NEUROTOMY
National Imaging Associates, Inc. Clinical guidelines FACET JOINT INJECTIONS, MEDIAL BRANCH BLOCKS, AND FACET JOINT RADIOFREQUENCY NEUROTOMY CPT Codes: Refer to pages 5 and 6 LCD ID Number: L35936 J K
More informationSubthalamic Nucleus Deep Brain Stimulation (STN-DBS)
Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) A Neurosurgical Treatment for Parkinson s Disease Parkinson s Disease Parkinson s disease is a common neurodegenerative disorder that affects about
More informationMedical Policy An Independent Licensee of the Blue Cross and Blue Shield Association
Implanted Peripheral Nerve Stimulator (PNS) Page 1 of 6 Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association Title: Implanted Peripheral Nerve Stimulator (PNS) for Pain
More informationParkinson disease: Parkinson Disease
Surgical Surgical treatment treatment for for Parkinson disease: Parkinson Disease the Present and the Future the Present and the Future Olga Klepitskaya, MD Associate Professor of Neurology Co-Director,
More informationSee Policy CPT/HCPCS CODE section below for any prior authorization requirements
Effective Date: 7/1/2018 Section: MED Policy No: 123 Medical Officer 7/1/18 Date Technology Assessment Committee Approved Date: 10/10; 12/15 Medical Policy Committee Approved Date: 8/94; 7/96; 8/97; 4/98;
More informationPAIN MANAGEMENT CODES PRIOR AUTHORIZATION REQUIRED THROUGH EVICORE HEALTHCARE
PAIN MANAGEMENT CODES PRIOR AUTHORIZATION REQUIRED THROUGH EVICORE HEALTHCARE The following CPT/HCPCS codes for pain management require prior authorization through evicore healthcare. In order to request
More informationDeep Brain Stimulation
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
More informationBasal ganglia motor circuit
Parkinson s Disease Basal ganglia motor circuit 1 Direct pathway (gas pedal) 2 Indirect pathway (brake) To release or augment the tonic inhibition of GPi on thalamus Direct pathway There is a tonic inhibition
More informationDeep Brain Stimulation: Surgical Process
Deep Brain Stimulation: Surgical Process Kia Shahlaie, MD, PhD Assistant Professor Bronte Endowed Chair in Epilepsy Research Director of Functional Neurosurgery Minimally Invasive Neurosurgery Department
More informationDeep Brain Stimulation. Is It Right for You?
Deep Brain Stimulation Is It Right for You? Northwestern Medicine Deep Brain Stimulation What is DBS? Northwestern Medicine Central DuPage Hospital is a regional destination for the treatment of movement
More informationGeneral remarks on Neurorejuvenation Spinal Cord Stimulation (SCS) Program Occipital Nerve Stimulation Gamma-knife for Trigeminal Neuralgia
General remarks on Neurorejuvenation Spinal Cord Stimulation (SCS) Program Occipital Nerve Stimulation Gamma-knife for Trigeminal Neuralgia Deep brain Stimulation (DBS) Program Neuromodulation is a field
More informationChapter 4 Section 20.1
Surgery Chapter 4 Section 20.1 Issue Date: August 29, 1985 Authority: 32 CFR 199.4(c)(2) and (c)(3) Copyright: CPT only 2006 American Medical Association (or such other date of publication of CPT). All
More informationPatient selection for surgery: Parkinson s disease
Patient selection for surgery: Parkinson s disease Dr. María C. Rodríguez-Oroz Neurology and Neuroscience. University Hospital Donostia, Research Institute BioDonostia, Ikerbasque Senior Researcher San
More informationResponsive Neurostimulation for the Treatment of Refractory Partial Epilepsy
Responsive Neurostimulation for the Treatment of Refractory Partial Epilepsy Policy Number: 7.01.143 Last Review: 8/2017 Origination: 8/2015 Next Review: 8/2018 Policy Blue Cross and Blue Shield of Kansas
More informationDEEP BRAIN AND CORTICAL STIMULATION
DEEP BRAIN AND CORTICAL STIMULATION UnitedHealthcare Oxford Clinical Policy Policy Number: SURGERY 090.17 T2 Effective Date: March 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 CONDITIONS OF
More informationShaheen Shaikh, M.D. Assistant Professor of Anesthesiology, University of Massachusetts Medical center, Worcester, MA.
Shaheen Shaikh, M.D. Assistant Professor of Anesthesiology, University of Massachusetts Medical center, Worcester, MA. Shobana Rajan, M.D. Associate staff Anesthesiologist, Cleveland Clinic, Cleveland,
More informationParkinson s Disease Webcast January 31, 2008 Jill Ostrem, M.D. What is Parkinson s Disease?
Parkinson s Disease Webcast January 31, 2008 Jill Ostrem, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of UCSF Medical Center, its medical staff or Patient
More informationGastric Electrical Stimulation
Gastric Electrical Stimulation Policy Number: 7.01.73 Last Review: 6/2017 Origination: 7/2002 Next Review: 6/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will not provide coverage for
More informationDEEP BRAIN AND CORTICAL STIMULATION
Oxford DEEP BRAIN AND CORTICAL STIMULATION UnitedHealthcare Oxford Clinical Policy Policy Number: SURGERY 090.19 T2 Effective Date: January 1, 2019 Instructions for Use Table of Contents Page CONDITIONS
More informationDEEP BRAIN AND CORTICAL STIMULATION
UnitedHealthcare of California (HMO) UnitedHealthcare Benefits Plan of California (EPO/POS) UnitedHealthcare of Oklahoma, Inc. UnitedHealthcare of Oregon, Inc. UnitedHealthcare Benefits of Texas, Inc.
More informationPOLICIES AND PROCEDURE MANUAL
POLICIES AND PROCEDURE MANUAL Policy: MP091 Section: Medical Benefit Policy Subject: Sacral Nerve Stimulation I. Policy: Sacral Nerve Stimulation II. Purpose/Objective: To provide a policy of coverage
More informationThe Surgical Management of Essential Tremor
The Surgical Management of Essential Tremor International Essential Tremor Foundation Learning About Essential Tremor: Diagnosis and Treatment Options Albuquerque, NM September 24, 2005 Neurosurgeon Overview:
More informationDeep Brain Stimulation
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
More informationWHAT DEFINES YOPD? HANDLING UNIQUE CONCERNS REBECCA GILBERT, MD, PHD VICE PRESIDENT, CHIEF SCIENTIFIC OFFICER, APDA MARCH 14, 2019
WHAT DEFINES YOPD? HANDLING UNIQUE CONCERNS REBECCA GILBERT, MD, PHD VICE PRESIDENT, CHIEF SCIENTIFIC OFFICER, APDA MARCH 14, 2019 YOUNG ONSET PARKINSON S DISEASE Definition: Parkinson s disease diagnosed
More informationCOMMONLY BILLED CODES
COMMONLY BILLED CODES SACRAL NEUROMODULATION FOR BLADDER CONTROL OR BOWEL CONTROL EFFECTIVE JANUARY 2018 UC201002977oEN Medtronic provides this information for your convenience only. It does not constitute
More informationDeep Brain Stimulation
MEDICAL POLICY 7.01.63 Deep Brain Stimulation BCBSA Ref. Policy: 7.01.63 Effective Date: July 1, 2017 Last Revised: Jan. 1, 2018 Replaces: N/A RELATED MEDICAL POLICIES: 7.01.20 Vagus Nerve Stimulation
More informationClinical Policy: Spinal Cord Stimulation Reference Number: PA.CP.MP.117
Clinical Policy: Reference Number: PA.CP.MP.117 Effective Date: 01/18 Last Review Date: 06/18 Coding Implications Revision Log Description The dorsal column stimulator (DCS), or spinal column stimulator
More informationDeep brain stimulation: What can patients expect from it?
MEDICAL GRAND ROUNDS ANDRE MACHADO, MD, PhD* Director, Center for Neurological Restoration, Neurological Institute, Cleveland Clinic HUBERT H. FERNANDEZ, MD Section Head, Movement Disorders, Center for
More informationPERCUTANEOUS FACET JOINT DENERVATION
Status Active Medical and Behavioral Health Policy Section: Surgery Policy Number: IV-95 Effective Date: 10/22/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members should
More information8/28/18. Anesthetic considerations for patients with implanted devices for treating chronic pain and more. Objectives:
Anesthetic considerations for patients with implanted devices for treating chronic pain and more Alaa Abd-Elsayed, MD, MPH Medical Director, UW Pain Services Medical Director, Pain Clinic Section Head,
More informationEfficient Feature Extraction and Classification Methods in Neural Interfaces
Efficient Feature Extraction and Classification Methods in Neural Interfaces Azita Emami Professor of Electrical Engineering and Medical Engineering Next Generation Therapeutic Devices 2 Where We Started:
More informationCoding for Sacral Neuromodulation
301.273.0570 Fax 301.273.0778 Coding for Sacral Neuromodulation Sacral Neuromodulation (SNS) is a widely used technique in Female Pelvic Medicine and Reconstructive Surgery (FPMRS), with several FDA-approved
More informationOccipital Nerve Stimulation Corporate Medical Policy
Occipital Nerve Stimulation Corporate Medical Policy File Name: Occipital Nerve Stimulation File Code: UM.SPSVC.14 Origination: 2011 Last Review: 06/2018 Next Review: 06/2019 Effective Date: 10/01/2018
More information2014 AAPM 56 th Annual Meeting
2014 AAPM 56 th Annual Meeting SAM Diagnostic Radiology MR Safety - Deep Brain Stimulator and Other Neurostimulators Yunhong Shu, Ph.D. Mayo Clinic, Rochester, MN Outline Background of Neurostimulator
More informationDeep Brain Stimulation for Movement Disorders
1 2 Deep Brain Stimulation for Movement Disorders Overview Deep brain stimulation (DBS) is a surgery to implant a device that sends electrical signals to brain areas responsible for body movement. Electrodes
More informationSee Policy CPT CODE section below for any prior authorization requirements. This policy applies to:
Effective Date: 1/1/2019 Section: MED Policy No: 108 Medical Officer 1/1/19 Date Medical Policy Committee Approved Date: 6/12; 9/12; 7/13; 10/13; 12/13; 11/14; 1/15; 12/15; 4/16; 12/16; 7/17; 8/17; 12/17;
More informationClinical Policy: Spinal Cord Stimulation Reference Number: CP.MP.117
Clinical Policy: Reference Number: CP.MP.117 Effective Date: 07/16 Last Review Date: 07/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and
More informationSympathetic Electrical Stimulation Therapy for Chronic Pain
Sympathetic Electrical Stimulation Therapy for Chronic Pain Policy Number: 015M0076A Effective Date: April 01, 015 RETIRED 5/11/017 Table of Contents: Page: Cross Reference Policy: POLICY DESCRIPTION COVERAGE
More informationActiva RC and Activa PC
Activa RC and Activa PC neurostimulators for deep brain stimulation From the company with the most experience in DBS The Activa Family Innovative programming platform More choices for patients With the
More informationDeep Brain Stimulation for Movement Disorders
Deep Brain Stimulation for Movement Disorders Overview Deep brain stimulation (DBS) is a surgery to implant a device that sends electrical signals to brain areas responsible for body movement. Electrodes
More informationHealthTalks. Deep Brain Stimulation for Parkinson s Disease Patients
HealthTalks Parkinson s Disease and Wellness Ali Rezai, MD Neurological Institute Director, Center for Neurological Restoration Cleveland Clinic Appointments: 216.444.4720 Deep Brain Stimulation for Parkinson
More informationIntroduction to Neurosurgical Subspecialties:
Introduction to Neurosurgical Subspecialties: Functional Neurosurgery Brian L. Hoh, MD 1 and Gregory J. Zipfel, MD 2 1 University of Florida, 2 Washington University Functional Neurosurgery Functional
More informationReimbursement Information for Diagnostic Musculoskeletal Ultrasound and Ultrasound-guided Procedures 1
GE Healthcare Reimbursement Information for Diagnostic Musculoskeletal Ultrasound and Ultrasound-guided Procedures 1 January, 2013 www.gehealthcare.com/reimbursement This overview addresses coding, coverage,
More informationClinical Policy: Gastric Electrical Stimulation
Clinical Policy: Reference Number: CP.MP.40 Last Review Date: 08/18 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Description
More informationProtocol. Deep Brain Stimulation
Protocol Deep Brain Stimulation (70163) Medical Benefit Effective Date: 07/01/15 Next Review Date: 05/18 Preauthorization No Review Dates: 09/07, 11/08, 09/09, 09/10, 09/11, 07/12, 05/13, 05/14, 05/15,
More informationClinical Commissioning Policy Proposition:
Clinical Commissioning Policy Proposition: Stereotactic Radiosurgery (SRS) for adults with Parkinson's tremor and Familial Essential Tremor Version Number: NHS England B13X06/01 Information Reader Box
More information2012 CPT Coding Update AANS/CNS Joint Section on Disorders of the Spine and Peripheral Nerves
2012 CPT Coding Update AANS/CNS Joint Section on Disorders of the Spine and Peripheral Nerves Joseph S. Cheng, M.D., M.S. Associate Professor of Neurological Surgery, Orthopedic Surgery, and Rehabilitation
More information